|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benezra R, Davis RL, Lockshon D, et al:
The protein Id: a negative regulator of helix-loop-helix DNA
binding proteins. Cell. 61:49–59. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prabhu S, Ignatova A, Park ST and Sun XH:
Regulation of the expression of cyclin-dependent kinase inhibitor
p21 by E2A and Id proteins. Mol Cell Biol. 17:5888–5896.
1997.PubMed/NCBI
|
|
5
|
Iavarone A, Garg P, Lasorella A, et al:
The helix-loop-helix protein Id-2 enhances cell proliferation and
binds to the retinoblastoma protein. Genes Dev. 8:1270–1284. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lasorella A, Iavarone A and Israel MA: Id2
specifically alters regulation of the cell cycle by tumor
suppressor proteins. Mol Cell Biol. 16:2570–2578. 1996.PubMed/NCBI
|
|
7
|
Lasorella A, Uo T and Iavarone A: Id
proteins at the cross-road of development and cancer. Oncogene.
20:8326–8333. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yokota Y and Mori S: Role of Id family
proteins in growth control. J Cell Physiol. 190:21–28. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lyden D, Young AZ, Zagzag D, et al: Id1
and Id3 are required for neurogenesis, angiogenesis and
vascularization of tumour xenografts. Nature. 401:670–677. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Norton JD: ID helix-loop-helix proteins in
cell growth, differentiation and tumorigenesis. J Cell Sci.
113:3897–3905. 2000.PubMed/NCBI
|
|
11
|
Sikder HA, Devlin MK, Dunlap S, et al: Id
proteins in cell growth and tumorigenesis. Cancer Cell. 3:525–530.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang HY, Liu HL, Liu GY, et al: Expression
and prognostic values of Id-1 and Id-3 in gastric adenocarcinoma. J
Surg Res. 167:258–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao ZR, Zhang ZY, Zhang H, et al:
Overexpression of Id-1 protein is a marker in colorectal cancer
progression. Oncol Rep. 19:419–424. 2008.PubMed/NCBI
|
|
14
|
Forootan SS, Wong YC, Dodson A, et al:
Increased Id-1 expression is significantly associated with poor
survival of patients with prostate cancer. Hum Pathol.
38:1321–1329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo KJ, Wen J, Xie X, et al: Prognostic
relevance of Id-1 expression in patients with resectable esophageal
squamous cell carcinoma. Ann Thorac Surg. 93:1682–1688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun W, Guo MM, Han P, et al: Id-1 and the
p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma
cells and are correlated with poor prognosis. Carcinogenesis.
33:810–817. 2012.
|
|
17
|
Cheng YJ, Tsai JW, Hsieh KC, et al: Id1
promotes lung cancer cell proliferation and tumor growth through
Akt-related pathway. Cancer Lett. 307:191–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sumida T, Murase R, Onishi-Ishikawa A, et
al: Targeting Id1 reduces proliferation and invasion in aggressive
human salivary gland cancer cells. BMC Cancer. 13:1412013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wilson JW, Deed RW, Inoue T, et al:
Expression of Id helix-loop-helix proteins in colorectal
adenocarcinoma correlates with p53 expression and mitotic index.
Cancer Res. 61:8803–8810. 2001.PubMed/NCBI
|
|
20
|
O’Brien CA, Kreso A, Ryan P, et al: ID1
and ID3 regulate the self-renewal capacity of human colon
cancer-initiating cells through p21. Cancer Cell. 21:777–792.
2012.PubMed/NCBI
|
|
21
|
Okaji Y, Tsuno NH, Kitayama J, et al:
Effects of down-regulating the Id genes in human colorectal
cancer cells on early steps of haematogenous metastasis. Eur J
Cancer. 42:668–673. 2006.PubMed/NCBI
|
|
22
|
Alani RM, Young AZ and Shifflett CB: Id1
regulation of cellular senescence through transcriptional
repression of p16/Ink4a. Proc Natl Acad Sci USA. 98:7812–7816.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pillai S, Rizwani W, Li X, et al: ID1
facilitates the growth and metastasis of non-small cell lung cancer
in response to nicotinic acetylcholine receptor and epidermal
growth factor receptor signaling. Mol Cell Biol. 31:3052–3067.
2011. View Article : Google Scholar
|
|
24
|
Li W, Zhang CH, Hong YL, et al: Inhibitor
of DNA-binding-1/inhibitor of differentiation-1 (ID-1) is
implicated in various aspects of gastric cancer cell biology. Mol
Biol Rep. 39:3009–3015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Wang H, Kuang CY, et al: An
essential role for the Id1/PI3K/Akt/NFκB/survivin signalling
pathway in promoting the proliferation of endothelial progenitor
cells in vitro. Mol Cell Biochem. 363:135–145. 2012.PubMed/NCBI
|
|
26
|
Ye Q, Cai W, Zheng Y, et al: ERK and AKT
signaling cooperate to translationally regulate survivin expression
for metastatic progression of colorectal cancer. Oncogene. Apr
29–2013.(Epub ahead of print). View Article : Google Scholar
|
|
27
|
Zhong W, Peng J, He H, et al: Ki-67 and
PCNA expression in prostate cancer and benign prostatic
hyperplasia. Clin Invest Med. 31:E8–E15. 2008.PubMed/NCBI
|
|
28
|
Tobin NP, Sims AH, Lundgren KL, Lehn S and
Landberg G: Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer.
11:4172011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li B, Tsao SW, Li YY, et al: Id-1 promotes
tumorigenicity and metastasis of human esophageal cancer cells
through activation of PI3K/AKT signaling pathway. Int J Cancer.
125:2576–2585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ling YX, Tao J, Fang SF, Hui Z and Fang
QR: Downregulation of Id1 by small interfering RNA in prostate
cancer PC3 cells in vivo and in vitro. Eur J Cancer Prev. 20:9–17.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato Y: Molecular diagnosis of tumor
angiogenesis and anti-angiogenic cancer therapy. Int J Clin Oncol.
8:200–206. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su Y, Gao L, Teng L, Wang Y, et al: Id1
enhances human ovarian cancer endothelial progenitor cell
angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways. J
Transl Med. 11:1322013.PubMed/NCBI
|
|
33
|
Shuno Y, Tsuno NH, Okaji Y, et al: Id1/Id3
knockdown inhibits metastatic potential of pancreatic cancer. J
Surg Res. 161:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim J, Takeuchi H, Lam ST, et al:
Chemokine receptor CXCR4 expression in colorectal cancer
patients increases the risk for recurrence and for poor survival. J
Clin Oncol. 23:2744–2753. 2005.
|
|
35
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kucia M, Reca R, Miekus K, et al:
Trafficking of normal stem cells and metastasis of cancer stem
cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4
axis. Stem Cells. 23:879–894. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang SS, Han ZP, Jing YY, et al:
CD133+CXCR4+ colon cancer cells exhibit
metastatic potential and predict poor prognosis of patients. BMC
Med. 10:852012.PubMed/NCBI
|
